CAPSID ASSEMBLY MODULATOR DOSING REGIMEN
The present disclosure is directed to methods of using a capsid assembly inhibitor for the treatment of hepatitis B virus infection.
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
20.01.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure is directed to methods of using a capsid assembly inhibitor for the treatment of hepatitis B virus infection. |
---|---|
Bibliography: | Application Number: EP20190729347 |